Smead Capital Management disclosed 27 US equity positions worth $3.8bn in its Q3 2022 13F filing. Its largest position is CLRUSD at 12.3% of the reported book, followed by OXY and AMGN. Versus Q2 2022 it opened 0 new positions, added to 20, reduced 6 and exited 4.
$3.8bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
27
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
12.3%
Largest position
The largest single position as a share of the reported equity book.
63.4%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
18
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.